Don't skip Stanley's limited-edition Oasis collection of tumblers and barware
It is looking like we're going to have a very Stanley summer. With the brand's recent Target-exclusive collection of pastel-hued tumblers to the latest resort-worthy Oasis collection, the brand is prepping us to stay hydrated in style this season.
Stanley 1913's dazzling limited-edition Oasis capsule collection feels like a snapshot out of White Lotus. The new launch features classic Quencher H2.0 FlowState Tumblers and backyard party essentials like The Everyday Slim Can Cooler Cup and the Adventure Fast Flow Water Jug in the prettiest patterns and hues.
Inspired by the vibrancy of a tropical oasis, Stanley's new hues include sophisticated stripes in Cornflower Cabana Gloss and Peach Whip Cabana Gloss, timeless tones like Cream Rose Gold, preppy patterns in Peach Whip Sunflower and Butter Sunflower, and more! Whether you're lounging by the pool, hosting a summer soiree or simply on-the-go this season, these exclusive new Stanley cups and accessories are perfect for making a statement.
Shop the new Stanley Oasis collection
Shop the new Stanley Oasis collection for summer 2025
1. Stanley The Quencher H2.0 FlowState Tumbler | 40-Ounce | Cornflower Cabana Gloss | Peach Whip Cabana Gloss
Stanley The Quencher H2.0 FlowState Tumbler | 40-Ounce | Cornflower Cabana Gloss | Peach Whip Cabana Gloss
Shop the limited-edition Stanley Oasis collection for new tumblers and barware in chic summer colors.
$45 at Stanley 1913
2. Stanley The Quencher H2.0 FlowState Tumbler | 30-Ounce | Butter Cabana Gloss
Stanley The Quencher H2.0 FlowState Tumbler | 30-Ounce | Butter Cabana Gloss
Shop the limited-edition Stanley Oasis collection for new tumblers and barware in chic summer colors.
$35 at Stanley 1913
3. Stanley The Quencher ProTour Flip Straw Tumbler | 40-Ounce | Cream Rose Gold
Stanley The Quencher ProTour Flip Straw Tumbler | 40-Ounce | Cream Rose Gold
Shop the limited-edition Stanley Oasis collection for new tumblers and barware in chic summer colors.
$45 at Stanley 1913
4. Stanley The Quencher ProTour Flip Straw Tumbler | 30-Ounce | Peach Whip Gloss
Stanley The Quencher ProTour Flip Straw Tumbler | 30-Ounce | Peach Whip Gloss
Shop the limited-edition Stanley Oasis collection for new tumblers and barware in chic summer colors.
$35 at Stanley 1913
5. Stanley The Quencher H2.O FlowState Tumbler With Handle | 20-Ounce | Peach Whip Sunflower
Stanley The Quencher H2.O FlowState Tumbler With Handle | 20-Ounce | Peach Whip Sunflower
Shop the limited-edition Stanley Oasis collection for new tumblers and barware in chic summer colors.
$30 at Stanley 1913
6. Stanley Adventure Fast Flow Water Jug | 2-Gallon | Cream Royal
Stanley Adventure Fast Flow Water Jug | 2-Gallon | Cream Royal
Shop the limited-edition Stanley Oasis collection for new tumblers and barware in chic summer colors.
$55 at Stanley 1913
7. Stanley The Everyday Slim Can Cooler Cup | 10-Ounce | Peach Whip Cabana Gloss
Stanley The Everyday Slim Can Cooler Cup | 10-Ounce | Peach Whip Cabana Gloss
Shop the limited-edition Stanley Oasis collection for new tumblers and barware in chic summer colors.
$25 at Stanley 1913
8. Stanley The Everyday Can Cooler Cup | 10-Ounce | Butter Sunflower
Stanley The Everyday Can Cooler Cup | 10-Ounce | Butter Sunflower
Shop the limited-edition Stanley Oasis collection for new tumblers and barware in chic summer colors.
$25 at Stanley 1913
More: Stanley Tumblers always sell out. Shop new arrivals that are still available
9. Stanley Classic Legendary Bottle | 1.1-Quart | Cream Rose Gold
Stanley Classic Legendary Bottle | 1.1-Quart | Cream Rose Gold
Shop the limited-edition Stanley Oasis collection for new tumblers and barware in chic summer colors.
$36 at Stanley 1913
10. Stanley Adventure Stacking Beer Pint | 16-Ounce | Butter Gloss
Stanley Adventure Stacking Beer Pint | 16-Ounce | Butter Gloss
Shop the limited-edition Stanley Oasis collection for new tumblers and barware in chic summer colors.
$20 at Stanley 1913
11. Stanley Classic Legendary Useful Box | 1.25-Quart | Peach Whip Gloss
Stanley Classic Legendary Useful Box | 1.25-Quart | Peach Whip Gloss
Shop the limited-edition Stanley Oasis collection for new tumblers and barware in chic summer colors.
$35 at Stanley 1913
More: The Stanley IceFlow comes in fresh new colors—shop them all here
Shop the new Stanley Oasis collection
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
How Much Will S&P 500 Companies Benefit From AI Adoption?
Key Takeaways Morgan Stanley estimates AI adoption could translate into annual net benefits of some $920 billion for S&P 500 companies, though it could take years to achieve and there is substantial risk that the benefits won't be fully realized. AI could address shortfalls in the labor market "rather than killing jobs," according to Morgan Stanley. Wells Fargo economists say the "high-tech" category currently accounts for a modest portion of U.S. manufacturing, but is poised to expand. Artificial intelligence giveth and taketh away, but it might be more of the former than the latter. Morgan Stanley estimates the annual net economic benefit in AI adoption alone could lead to roughly $920 billion, or about 28% of S&P 500 estimated consensus pretax earnings for 2026, after implementation costs. That would translate into $13 trillion to $16 trillion in market value creation. The firm's analysts note, however, that it would take many years to achieve, with substantial risk of companies not realizing the benefits of full adoption. That economic value creation is expected to come from a mix of cost cutting as well as new revenue and margin generation, Morgan Stanley strategists including Stephen Byrd wrote in the report. The value is expected to come from an almost even split between agentic AI, or software, and embodied AI, human-like robots. Adoption of new technology, including artificial intelligence, could be a net positive for the job market, contrary to fears of becoming obsolete, or FOBO, per analysts and economists. Though job displacement is possible, underlying labor market trends point to a glass half full. "Rather than killing jobs, AI might address a shortfall in workers," the analysts wrote in the report. Consider comparably impactful technological advances including the adoption of the computer, which in the 1990s led to an influx of jobs for computer scientists and programmers, and the biggest declines for secretaries, bookkeepers, accountants, and auditing clerks, the report has applied quantitative analysis to identify jobs that were the most and least exposed to AI, using a dataset of 200,000 anonymized conversations between users and its public generative AI system Bing Copilot. Jobs most exposed to AI involve brains, and those least exposed, brawn. Spending in new tech taken together—in software; research and development; information processing equipment; and manufacturing facility construction—show business leaders' prioritizing investments of that ilk more than any other category, Wells Fargo economists wrote in a report published Monday. Analyzing spending solely in equipment also shows firms putting a down payment on a "high-tech future," allocating more in information processing than transports and industrial equipment, combined, they said."This might be just the beginning of a high-tech production boom," the firm's economists Shannon Grein and Tim Quinlan wrote. "High-tech currently accounts for just around 3% of domestic manufacturing in the U.S., but capacity looks set to expand amid the evolution in the sorts of factories we're building in America today." Read the original article on Investopedia Sign in to access your portfolio
Forbes
16 hours ago
- Forbes
The Trump Administration Is Reviving Its Worst Drug Pricing Policies
It's been a big year for revivals. There's a new Jurassic Park movie, a reunion tour featuring 1990s rock band Oasis, and a Harry Potter television series in the works. President Trump is also looking to revive some of the policies he tried to enact during his first term. He recently issued an executive order aimed at compelling pharmaceutical companies to sell drugs in the United States at the lowest price available in other developed countries. He upped the ante late last month by writing several major drug companies—including Pfizer, Eli Lilly, and Johnson & Johnson—informing them that they had to comply with his 'Most Favored Nation' order. This order is just an attempt to import foreign price controls. By undercutting manufacturers' ability to set prices for their products, Most Favored Nation could reduce access to novel drugs in America, slow innovation, and disrupt the market incentives that deliver the low-priced generic drugs that account for the vast majority of prescriptions in this country. Most foreign governments cap drug prices as a means of controlling costs in their government-run healthcare systems. Germany and Canada, for example, underpay for breakthrough drugs by roughly 90%. The Trump administration views the discrepancy between what the United States and what foreign countries pay for drugs as a bad deal. Hence, the directive to import foreign prices here. But drug companies are unlikely to just bow to the president's order that they lower their prices. Let's assume the order is legally enforceable—a dubious proposition. Drug makers may respond by pulling their products from reference countries—if they're available at all there. They may delay the introduction of new drugs subject to most favored nation pricing in the United States. Or they may raise prices abroad such that the reference prices don't lead to any savings here. These aren't hypotheticals. Drug makers often respond to foreign countries' threat of price controls on their novel medicines by delaying or even refusing to launch their products there. Fewer than one in four new drugs launched between 2012 and 2021 debuted in Europe. And of all the new drugs launched in that timeframe, less than four in ten were available in the G20 group of developed nations, on average, in October 2022. By contrast, nearly 60% of new drugs launched between 2012 and 2021 debuted in the United States. And 85% of those drugs were available in the United States as of October 2022. Foreign governments are willing to sacrifice access to new, life-saving medicines for price controls. That's the trade Most Favored Nation would make for Americans—whether they like it or not. Now let's assume Most Favored Nation delivers the savings its proponents promise. In so doing, it would deprive drug makers of the revenue they use to discover the next generation of effective therapies and deliver them to patients. The United States shoulders the lion's share of the global biopharmaceutical research and development tab in 2021—some 55% of the $276 billion spent in 2021. That investment would necessarily plummet under Most Favored Nation. Then there's the order's potential impact on generic drugs. These unbranded copies of innovator medicines that can hit the market after the innovator's intellectual property protections expire, account for around 93% of all prescriptions filled in the United States. And generics are anywhere between 80% and 85% cheaper than branded drugs, on average. The more generic competitors enter the market, the more prices fall. Most Favored Nation destroys the incentive for generics makers to enter the market. With branded medicines subject to price controls, there's little room for generics manufacturers to capture market share by competing on price. Given that economic reality, it's unsurprising that generics prices in other countries are higher than in the United States. Combine that fact with the huge volume of generics dispensed, and public-sector net drug prices are actually 18% lower, on average, in the United States than in peer countries, according to research from three University of Chicago economists. It's understandable to look at lower drug prices abroad with envy. But those low prices come at significant cost in terms of access. Importing those low prices via Most Favored Nation remains a bad deal for American patients.
Forbes
21 hours ago
- Forbes
Cool Britannia's Back As Topshop Struts Out Online And With New Stores
The Gallagher brothers are touring and Topshop is strutting its stuff at the famous Trafalgar Square in London. It all feels very Cool Britannia in a summer of 90s revivals, as two of the U.K.'s biggest cultural icons take centre stage once again. Oasis are already well through the U.K. and Irish legs of their reunion tour before they prepare to take off for North America but this weekend that tide of retro revivals was joined by the debut of the long-flagged Topshop revival. To grab the headlines, famous names including models Cara Delevingne and Adwoa Aboah, alongside Mayor of London Sadiq Khan, were in attendance to back Topshop's highly anticipated return after the fashion retailer shuttered operations in 2020 following the collapse of its parent company, Sir Philip Green's Arcadia Group. At its peak, Topshop was a global rival for the likes of H&M and the Inditex brands, but its collapse and the financial downturns that engulfed Green led to the closure of all Topshop's stores, including its famous flagship at Oxford Circus, now home to Swedish furniture giant IKEA, plus all its U.S. stores. Although the brand found a new home as part of the stable of brands within online fashion giant Asos, it had not had its own independent website until now but on August 15 that all changed as the brand relaunched its website and celebrated its comeback Saturday with a public runway show in Trafalgar Square. Topshop Stores Slated For Fall Topshop is now under new owners, Danish retail giant Bestseller holds 75% of the company through its Heartland investment arm, while Asos has retained a 25% stake in the retail brand. Standalone stores are also set to return to the high street Topshop and Topman Managing Director Michelle Wilson attested at the launch, as she affirmed that a high street presence is scheduled to roll out later this year, with permanent standalone stores slated for this Fall. The Trafalgar Square event was Topshop's first runway show since 2018 and was held as a public event and featured some of the brand's original famous model names, including Delevingne and Aboah, and took place amid suitable fanfare and in front of the awaiting tv cameras. It showcased the upcoming autumn/winter 2025 collection, available to buy immediately online with a 'see now, buy now' offer. Leather trench coats, maxi dresses and A-line skater skirts all featured in a collection that highlighted apparel as Topshop evoked the brand's heyday when global model icon Kate Moss was its best known public face. It was an offer that epitomised the retailer's cheap chic look, which helped create the consumer trend to combine designer clothes with fast fashion items. Topshop Reboot Elevates Brand For the reboot, Topshop is trying to position itself as an elevated fashion brand, upping the quality of its merchandise and doubling down on its cultural relevance, digging deep into the current vogue for nostalgia and targeting shoppers aged 18 to 40. After previously signalling its intentions to return through physical channels, Topshop has already kicked off plans to reappear in stores first via wholesale, starting with Irish department store McElhinney's where the first apparel will go on sale later this week. The big question is whether Topshop can ride the nostalgia trend back to the top. Many of its previous rivals still exist and have continued to expand over the past five years, while online giants such as Shein have emerged to sweep up Gen Z's seemingly endless thirst for fast fashion at affordable prices. The desire for retro and reminders of simpler times has seen many younger consumers digitally detox but at the same time their wallets are squeezed and they have endless choice, plus less brand loyalty. But for now, Topshop is back baby, and it's going to be down to its senior team and designer to recapture the zeitgeist and give British fashion and the world a welcome shot of Cool Brittania.
